Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP. Sedative for patients on ventilators currently in short supply in the US ... May 12
Under the terms of the agreement, Glenmark will be responsible for the continued development and regulatory approval of Ryaltrisâ„¢ by the US FDA, while Hikma ... Feb 28
-Advertisements-